Endovascular Stroke Treatment And Reteplase Protocol

NCT05900674 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Sponsor

Conditions

Ischemic Stroke

Interventions

DRUG: Reteplase Injection

Sponsor

Zeenat Qureshi Stroke Institute